Validation of TRPA1 and TRPV1 Antibodies for Expression Detection in Mammalian Cells and Tissues
Journal of Neurochemistry · 2026-04 · 170 (4)
DOI: 10.1111/jnc.70444 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Neurochemistry, online erschienen am 22.04.2026. Verfasst von M de Las Casas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain. Hauptthemen laut MEDLINE: TRPV Cation Channels, TRPA1 Cation Channel, Antibodies, Transient Receptor Potential Channels. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Generalitat Valenciana, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
Antibodies are key reagents in cell biology and biochemistry research. The validation of their performance, in terms of sensitivity and specificity, is essential for their correct application. TRPV1 and TRPA1 are non‐selective cation channels expressed in primary sensory neurons, where they mediate the detection of diverse physical and chemical stimuli. They play key roles in nociception and inflammatory processes, making them important targets for mechanistic and therapeutic pain studies, highlighting the need for reliable evaluation of their expression. The detection and quantification of TRPV1 and TRPA1 protein expression is commonly carried out using antibody‐based techniques, such as immunohistochemistry and western blotting. However, as with other TRP channels and membrane proteins, antibody performance is frequently suboptimal, leading to potential misinterpretation of results and erroneous conclusions. In this study, we systematically evaluated the performance of five TRPV1 and seven TRPA1 commercial antibodies in immunocytochemistry, immunohistochemistry, and western blotting, using both heterologous and native expression systems. We identified two TRPV1 antibodies that consistently yielded robust and specific signals across all techniques and expression models tested; their specificity was validated using a TRPV1 KO mouse. For the remaining antibodies, we provide guidance to facilitate the selection of the most appropriate reagent according to the experimental approach. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
ORCID-Profile: M de Las Casas, P Hernández-Ortego, E De la Peña, A Gomis, F Viana, J Fernández-Trillo
Förderung
- Ministerio de Ciencia e Innovación
- Generalitat Valenciana
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
de Las Casas, M., Hernández-Ortego, P., Torres-Montero, R., De la Peña, E., Gomis, A., Viana, F., & Fernández-Trillo, J. (2026). Validation of TRPA1 and TRPV1 Antibodies for Expression Detection in Mammalian Cells and Tissues. Journal of Neurochemistry, 170(4). https://doi.org/10.1111/jnc.70444
Vancouver
de Las Casas M, Hernández-Ortego P, Torres-Montero R, De la Peña E, Gomis A, Viana F, et al. Validation of TRPA1 and TRPV1 Antibodies for Expression Detection in Mammalian Cells and Tissues. Journal of Neurochemistry. 2026;170(4). doi:10.1111/jnc.70444
BibTeX
@article{deLasCasas2026,
author = {de Las Casas, M and Hernández-Ortego, P and Torres-Montero, R and De la Peña, E and Gomis, A and Viana, F and Fernández-Trillo, J},
title = {Validation of TRPA1 and TRPV1 Antibodies for Expression Detection in Mammalian Cells and Tissues},
journal = {Journal of Neurochemistry},
year = {2026},
volume = {170},
number = {4},
doi = {10.1111/jnc.70444}
}
EUVIMED